Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRN17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,155
Award facts
- Contract value 100% obligated
- $7,154.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,154.87 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other autoimmune conditions, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen continues to serve as a critical supplier for the Defense Health Agency and other government healthcare systems through this flexible contracting arrangement.
Quick answers
Who was awarded contract SPE2DB25FRN17?
SPE2DB25FRN17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FRN17 worth?
The government has obligated $7,155 on SPE2DB25FRN17.
Is contract SPE2DB25FRN17 an order under another contract?
Yes. SPE2DB25FRN17 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRN17 competed?
The extent of competition for SPE2DB25FRN17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award